Dr. Nominchimeg Dorj

Dr. Nominchimeg Dorj is a consultant rheumatologist at the First Central Hospital of Mongolia in Ulaanbaatar — one of Mongolia's principal tertiary referral hospitals and the country's leading centre for specialist internal medicine. With 15 years of rheumatology practice, Dr. Dorj is one of Mongolia's most experienced specialists in inflammatory joint disease and autoimmune conditions, managing patients referred from across Mongolia's vast but sparsely populated territory.

Rheumatology is a relatively young specialty in Mongolia, and Dr. Dorj has been part of the generation of specialist physicians who established modern rheumatological services in the country following Mongolia's democratic transition and healthcare reform. The First Central Hospital's rheumatology unit manages both inpatient and outpatient cases, including referrals from Mongolia's rural aimags (provinces) where patients may travel significant distances to access specialist care in Ulaanbaatar.

Mongolia has a distinctive disease pattern with high rates of gout — driven by dietary factors including red meat and alcohol consumption — and ankylosing spondylitis, which has a higher prevalence in East Asian and Central Asian populations. Dr. Dorj's expertise in these conditions, alongside her management of rheumatoid arthritis and connective tissue diseases, makes her one of Ulaanbaatar's most sought-after specialist physicians for musculoskeletal disease.

Dr. Dorj completed her medical degree at the Health Sciences University of Mongolia (HSUM) in Ulaanbaatar — the country's primary medical school. She completed her specialty in Rheumatology through the Mongolia Ministry of Health specialist certification programme, training at the First Central Hospital and the National Center for Communicable Disease.

She undertook advanced clinical training in rheumatology at Peking Union Medical College Hospital in Beijing, China — one of Asia's leading academic rheumatology centres — gaining exposure to modern DMARD and biologic therapy management, musculoskeletal ultrasound, and connective tissue disease management. She is a member of the Asia Pacific League of Associations for Rheumatology (APLAR) and participates in APLAR congress education programmes for continuing professional development.

Dr. Dorj's clinical expertise encompasses the full spectrum of inflammatory and non-inflammatory musculoskeletal disease. Her primary focus is rheumatoid arthritis — managing patients from initial diagnosis through DMARD initiation (methotrexate, leflunomide, sulfasalazine, hydroxychloroquine) and monitoring for disease activity and medication toxicity. Where biologics are available and affordable within Mongolia's healthcare funding context, she coordinates their use.

In gout management, she provides both acute management (NSAIDs, colchicine, corticosteroids) and long-term urate-lowering therapy with allopurinol or febuxostat, with attention to renal function and comorbidities. She diagnoses and manages ankylosing spondylitis, psoriatic arthritis, and reactive arthritis. For connective tissue disease, she interprets autoantibody panels and manages lupus, Sjogren's syndrome, and undifferentiated connective tissue disease with hydroxychloroquine and appropriate immunosuppression. She performs joint aspiration for diagnostic synovial fluid analysis and intraarticular corticosteroid injections.

The First Central Hospital of Mongolia serves patients primarily from Ulaanbaatar and referrals from Mongolia's provincial network. International patients — primarily from Russia, China, Japan, and South Korea — occasionally seek specialist rheumatological consultation in Ulaanbaatar. Dr. Dorj consults in Mongolian, Russian, and English.

For Mongolian patients living abroad — a significant diaspora community primarily in Russia, South Korea, and Germany — Dr. Dorj can provide in-person consultations when patients return to Mongolia and coordinate their ongoing care with physicians in their country of residence. She provides medical summary documentation in English for international referral purposes.

Dr. Dorj has been recognised by the Mongolian Society of Rheumatology for her contributions to the development of rheumatology specialist services in Mongolia. She has presented at APLAR regional rheumatology conferences on gout management and ankylosing spondylitis in Mongolian populations.

She serves as a faculty member in the HSUM postgraduate specialist training programme for internal medicine and rheumatology, training Mongolia's next generation of specialist physicians. She participates in WHO-supported non-communicable disease working groups for Mongolia and contributes to national rheumatology guidelines development.